Sodium-glucose cotransporter-2 inhibitor luseogliflozin added to glucagon-like peptide 1 receptor agonist liraglutide improves glycemic control with bodyweight and fat mass reductions in Japanese patients with type 2 diabetes: A 52-week, open-label, single-arm study

Seino Yutaka; Seino Yutaka; Yabe Daisuke; Sasaki Takashi; Fukatsu Atsushi; Imazeki Hisae; Ochiai Hidekazu; Sakai Soichi

Art

J-GLOBAL ID：201802222925688018 Reference number：18A0504041

Sodium-glucose cotransporter-2 inhibitor luseogliflozin added to glucagon-like peptide 1 receptor agonist liraglutide improves glycemic control with bodyweight and fat mass reductions in Japanese patients with type 2 diabetes: A 52-week, open-label, single-arm study

グルカゴン様ペプチド1受容体アゴニストのリラグルチドに添加されたナトリウム-グルコース共輸送体-2阻害剤ルセオグリフロジンは2型糖尿病の日本人患者で体重と脂肪量の減少を伴う血糖コントロールを改善する:52週の非盲検単一群研究

Publisher site {{ this.onShowPLink() }} Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=18A0504041&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0504041&from=J-GLOBAL&jstjournalNo=U0507A") }}

Author (8)： , , , , , , ,
Material：
Volume： 9 Issue： 2 Page： 332-340 Publication year： 2018
JST Material Number： U0507A ISSN： 2040-1124 Document type： Article
Article type：原著論文 Country of issue： United States (USA) Language： ENGLISH (EN)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0504041&from=J-GLOBAL&jstjournalNo=U0507A") }}

Author keywords (3)： , ,

Clinical application of drugs acting on carbohydrate metabolism , Treatment for metabolic diseases,nutritional diseases.

, , , , , , , , , , , , , , ,

Return to Previous Page